In-Silico Analysis of Phytocompounds of <i>Olea europaea</i> as Potential Anti-Cancer Agents to Target PKM2 Protein
Globally, cancer is the second leading cause of mortality and morbidity. The growth and development of cancer are extremely complex. It is caused by a variety of pathways and involves various types of enzymes. Pyruvate kinase M2 (PKM2) is an isoform of pyruvate kinase, that catalyses the last steps...
Main Authors: | Faizan Abul Qais, Suliman Yousef Alomar, Mohammad Azhar Imran, Md Amiruddin Hashmi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/18/5793 |
Similar Items
-
Identification of bioactive compounds of Zanthoxylum armatum as potential inhibitor of pyruvate kinase M2 (PKM2): Computational and virtual screening approaches
by: Mohd Afzal, et al.
Published: (2024-03-01) -
Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugs
by: Ipsita Pujari, et al.
Published: (2021-10-01) -
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues
by: Lin Li, et al.
Published: (2024-04-01) -
The Regulatory Network of hnRNPs Underlying Regulating <i>PKM</i> Alternative Splicing in Tumor Progression
by: Yuchao Li, et al.
Published: (2024-05-01) -
Revisiting glucose metabolism in cancer: lessons from a PKM knock-in model
by: Taku Sato, et al.
Published: (2018-07-01)